George Karpouzas, MD, on -2 Glycoprotein 1 IgA Antibodies and Coronary Outcomes in RA
In this podcast, George Karpouzas, MD, discusses his research that evaluated\xa0whether \u03b2-2 glycoprotein 1\xa0IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of inflammation on atherosclerosis among patients with rheumatoid arthritis. More at: www.consultan360.com/rheumatology